Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
4.535
+0.105 (2.37%)
Jul 27, 2026, 3:21 PM EDT - Market open

Bausch Health Companies Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Bausch Health Companies stock has a consensus rating of "Hold" and an average price target of $7.40. The average 1-year stock price forecast is 63.18% higher than the current stock price, while the lowest is $6.00 (+32.30%) and the highest is $9.00 (+98.46%).

Price Target: $7.40 (+63.18%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$6.00$7.40$7.00$9.00
Change+32.30%+63.18%+54.36%+98.46%
* Price targets were last updated on Jun 3, 2026.

Analyst Ratings

The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy000000
Buy111100
Hold888877
Sell000000
Strong Sell000000
Total999977

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Hold
Reiterates
$7
HoldReiterates$7+54.36%Jun 3, 2026
Truist Financial
Truist Financial
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 1, 2026
TD Cowen
TD Cowen
Hold
Maintains
$7
HoldMaintains$7+54.36%Apr 30, 2026
Evercore ISI
Evercore ISI
Hold
Maintains
n/a
HoldMaintainsn/an/aApr 30, 2026
RBC Capital
RBC Capital
Hold
Maintains
$9
HoldMaintains$9+98.46%Apr 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.73B
from 10.27B
Increased by 4.47%
Revenue Next Year
10.74B
from 10.73B
Increased by 0.15%
EPS This Year
4.30
from 3.75
Increased by 14.94%
EPS Next Year
4.11
from 4.30
Decreased by -4.54%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.43B8.12B8.76B9.63B10.27B10.73B
Revenue Growth
5.07%-3.68%7.79%9.91%6.66%4.47%
Gross Profit
6.04B5.76B6.20B6.84B7.25B7.63B
Gross Margin
71.61%70.90%70.78%71.10%70.65%71.17%
Operating Income
1.71B1.48B1.62B1.87B2.19B3.50B
Net Income
-948.00M-225.00M-592.00M-46.00M157.00M-161.50M
EPS
----3.754.30
EPS Growth
-----4.94%14.94%
Forward PE
5.921.702.111.901.671.05
Free Cash Flow
1.63B1.02B738.13M1.72B1.09B1.51B
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.8B
Avg10.7B
Low10.6B

Revenue Growth

Revenue Growth202620272028
High
5.5%
Avg
4.5%
Low
3.3%

EPS Forecast

EPS202620272028
High4.77
Avg4.30
Low4.03

EPS Growth

EPS Growth202620272028
High
27.4%
Avg
14.9%
Low
7.6%